Haleon Invests $54 Million in Richmond R&D Center to Enhance Product Innovation Pipeline
Healthcare conglomerate Haleon announced a $54 million investment in its Richmond, U.S., research and development (R&D) center. This investment aims to accelerate the development of innovative products and augment Haleon's global R&D capabilities.
The company revealed that the Richmond facility is one of its three primary R&D centers, alongside locations in Weybridge, UK, and Suzhou, China. This investment complements Haleon's existing annual R&D allocation of 300 million pounds ($372.5 million).
This strategic investment signals Haleon's ongoing commitment to driving innovation and meeting the evolving healthcare needs of consumers worldwide.